What is CycloPure?
CycloPure, Inc. operates at the intersection of environmental engineering and public health, specializing in the removal of per- and polyfluoroalkyl substances (PFAS) from water supplies. At the core of its technological portfolio is DEXSORB, a renewable adsorbent material engineered to capture and eliminate persistent chemical contaminants. The company provides a comprehensive suite of solutions, ranging from consumer-facing test kits to large-scale filtration systems designed for municipal and industrial infrastructure. By focusing on the fundamental necessity of safe drinking water, CycloPure has established itself as a critical player in the water treatment industry, effectively bridging the gap between advanced material science and practical, scalable environmental remediation.
How much funding has CycloPure raised?
CycloPure has raised a total of $4.2M across 2 funding rounds:
Series B
$4M
Debt
$181K
Series B (2019): $4M with participation from Undisclosed
Debt (2021): $181K led by PPP
Key Investors in CycloPure
Undisclosed Investors
PPP
Public-Private Partnership
What's next for CycloPure?
With the recent influx of capital, CycloPure is poised to expand its operational footprint and enhance its manufacturing capabilities for DEXSORB-based systems. The strategic roadmap likely involves deepening market penetration within the municipal water treatment sector, where the demand for effective PFAS mitigation is reaching a critical inflection point. Furthermore, the company is expected to invest in research and development to refine its adsorbent technology, potentially diversifying its product offerings to address emerging water quality challenges. As regulatory scrutiny regarding PFAS levels intensifies globally, CycloPure's ability to provide verifiable, high-efficiency filtration will be instrumental in securing long-term enterprise contracts and solidifying its market leadership in the water health sector.
See full CycloPure company page
